<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/METS/ https://www.loc.gov/standards/mets/mets.xsd" OBJID="oai:wwu.de:2feeeb4f-f2ef-4b1f-a725-f76997710ddb" LABEL="University of Muenster, Institutional Repository MIAMI"  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
          <mets:metsHdr CREATEDATE="2022-11-09T15:02:35">
            <mets:agent TYPE="OTHER" ROLE="OTHER" OTHERTYPE="SOFTWARE">
              <mets:name>Memory Alpha</mets:name>
            </mets:agent>
          </mets:metsHdr>
          <mets:dmdSec ID="DMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb">
            <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
              <mets:xmlData>
                <mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd" version="3.7">
                  <mods:titleInfo type="uniform" lang="eng">
                    <mods:title script="Latn">Syndecan-1 and heparanase as novel regulators of colon cancer stem cell function</mods:title>
                  </mods:titleInfo>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1077918445">
                    <mods:namePart type="given">Sampath Kumar</mods:namePart>
                    <mods:namePart type="family">Katakam</mods:namePart>
                    <mods:namePart type="date">1986-</mods:namePart>
                    <mods:displayForm>Katakam, Sampath Kumar</mods:displayForm>
                    <mods:affiliation>FB 13: Biologie</mods:affiliation>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/120035715">
                    <mods:namePart type="given">Martin</mods:namePart>
                    <mods:namePart type="family">Götte</mods:namePart>
                    <mods:namePart type="date">1967-</mods:namePart>
                    <mods:displayForm>Götte, Martin</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">ths</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Münster, Westfalen / ULB</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Münster, Westfalen / Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Westfalen / Universität Münster / Universitäts- und Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:genre>doctoralThesis</mods:genre>
                  <mods:genre authority="dct">Text</mods:genre>
                  <mods:originInfo>
                    <mods:dateIssued keyDate="yes">2015</mods:dateIssued>
                    <mods:dateOther>2015-08-19</mods:dateOther>
                    <mods:issuance>monographic</mods:issuance>
                  </mods:originInfo>
                  <mods:originInfo>
                    <mods:dateIssued encoding="w3cdtf">2015-10-23</mods:dateIssued>
                    <mods:dateModified encoding="w3cdtf">2015-10-23</mods:dateModified>
                    <mods:edition>[Electronic ed.]</mods:edition>
                  </mods:originInfo>
                  <mods:language>
                    <mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
                  </mods:language>
                  <mods:physicalDescription>
                    <mods:form>electronic</mods:form>
                    <mods:reformattingQuality>access</mods:reformattingQuality>
                    <mods:internetMediaType>application/pdf</mods:internetMediaType>
                    <mods:digitalOrigin>born digital</mods:digitalOrigin>
                  </mods:physicalDescription>
                  <mods:abstract lang="ger">Proteoglykane, Glykosaminoglykane und ihre degradierenden Enzyme spielen eine große Rolle innerhalb der Homeostase im normalen Gewebe als auch bei Krebs. Das Transmembran Heparansulfat Proteoglykan Syndekan-1 ist ein wesentliches Bestandteil des strukturellen Gerüsts im Darmgewebe. Das Ziel dieser Arbeit war es herauszufinden, ob die Expression von Syndekan-1 und HPSE Tumorstammzell-Eigenschaften und ihre Invasivität im Darmkrebs beeinflusst. Unsere Ergebnisse haben deutlich gezeigt, dass Syndekan-1 und HPSE innerhalb der Stammzellnische durch die Signalwege EGR1, pFAK und Wnt dynamisch miteinander interagieren. Das Targeting dieser Signalkaskaden könnte einen neuen therapeutischen Ansatz darstellen, um Darmkrebs künftig zu behandeln.</mods:abstract>
                  <mods:abstract lang="eng">Proteoglycans and glycosaminoglycans and their degradative enzymes &#13;
are involved in normal tissue homeostasis and cancer. The transmembrane &#13;
heparan sulfate proteoglycan Syndecan1 provides a structural framework &#13;
for proper tissue organization in the intestinal tract. The aim of this &#13;
thesis was to investigate whether expression of Sdc1 and HPSE influences&#13;
 cancer stem cell properties and invasiveness in colon cancer cell lines&#13;
 (Caco2 and HT29). Taken together, our results report for the first time&#13;
 showed the dynamic interplay between Sdc1 and HPSE in stemness &#13;
associated colon cancer properties via  signaling axis involving EGR1, &#13;
pFAK and Wnt. These findings could form a conceptual framework for &#13;
establishing novel therapeutic approaches to treat colon cancer.</mods:abstract>
                  <mods:tableOfContents lang="eng">1 Introduction..................………………………………………………………….1&#13;
1.1 Cancer……………………………………………………………………….1&#13;
1.1.1 Colon cancer………………………………………………………………1&#13;
1.2 Cancer stem cells (CSCs)……………………………………….. ……………. 2&#13;
1.2.1 CSCs share the three important hallmarks of stem cells…………...…..…..3&#13;
1.2.2 Five key characteristics of cancer stem cells ………………...…..…....…..3&#13;
1.2.3 Current approaches for isolating Cancer Stem Cells: ……...…..…....…….5&#13;
a) Cell surface markers (surface antigens)……………………… ……… 5&#13;
b) “Side-Population” Cells………………………………………………. 5&#13;
c) Aldehyde Dehydrogenase activity …………………………………… 5&#13;
d) Sphere Formation- direct functional assay…………………………… 6&#13;
1.2.4 CSCs as targets for therapeutic applications……………………………… 6&#13;
1.2.5 Cancer stem cells and their link to induced pluripotent stem cells ……….7&#13;
1.2.6 Contribution of CSCs to invasive cell behavior …………………………. 8&#13;
1.2.6.1 Epithelial to mesenchymal transition (EMT)..………………………… 8&#13;
1.2.6.2 Migrating CSCs……………………………………………………….. 10&#13;
1.2.6.3 De-Differentiation ……………………………………………………. 11&#13;
1.2.7 Colon cancer stem cells ……………………………………………………13&#13;
1.2.8 Colon cancer stem cells – Role of Wnt signaling ………………………... 14&#13;
1.3 Extracellular matrix dynamics………………………………………………… 15&#13;
1.3.1 ECM dynamics in cancer progression …………………………………... 16&#13;
1.3.2 Integrin signaling…………………………………………………………. 17&#13;
1.3.3 Interplay between Integrins and focal adhesion kinase (FAK) ………….. 17&#13;
1.4 Heparan sulfate proteoglycans…………………………………………………..18&#13;
1.4.1 Heparan sulfate proteoglycans and the stem cell niche……………………19&#13;
1.4.2 Syndecans …………………………………………………………………20&#13;
1.4.2.1 Syndecan-1………………………………………………………….. 21&#13;
1.4.2.1.1 Role of syndecan-1 in malignancy ……………………………… 22&#13;
1.4.3 Heparanase ……………………………………………………………… 24&#13;
a) Expression………………………………………………………………. 24&#13;
b) Role in Inflammation …………………………………………………. . 24&#13;
c) Role in Malignancy ……………………………………………………. 25&#13;
1.4.4 The Syndecan-1- heparanase axis ……………………………………….. 26&#13;
1.5 Aims of the thesis ……………………………………………………………... 28&#13;
2 Materials and methods…………………………………………..…………… 31&#13;
2.1 Materials ……………………………………………………………………30&#13;
2.1.1 Cell lines ……………………………………………………………… 30&#13;
2.1.2 Cell culture media und supplements ………………………………….. 31&#13;
2.1.3 Bacterial media ………………………………………………………. .32&#13;
2.1.4 Chemicals and Chemokines ………………………………………….. 32&#13;
2.1.5 Buffers and solutions&#13;
2.1.5.1 Buffers …………………………………………………………. 35&#13;
2.1.5.1.1 Protein chemistry and Western blot ……………………… 35&#13;
2.1.5.1.2 Cell viability assay (MTT) ………………………………. ..37&#13;
2.1.5.1.3 Cell adhesion assay……………………………………….. 37&#13;
2.1.5.1.4 Immunofluorescence microscopy ………………………… 38&#13;
2.1.5.1.5 Zymography ……………………………………………… 38&#13;
2.1.5.1.6 Molecular biology ………………………………………… 39&#13;
2.1.5.2 Solutions ready to use ………………………………………… 40&#13;
2.1.5.2.1 Antibodies ………………………………………………… 41&#13;
2.1.5.2.2 Oligonucleotide primers, Taq Man and SYBR primers …… 42&#13;
2.1.5.2.3 Reaction system (Kits) ………………………………………43&#13;
2.1.6 Equipment and Materials ……………………………………….…… 44&#13;
2.1.7 Softwares …………………………………………………………..…. 46&#13;
2.2 Methods …………………………………………………………………….. 47&#13;
2.2.1 Adherent cell culture ……………………………………………… 47&#13;
2.2.2 siRNA knockdown ………………………………………………. 47&#13;
2.2.3 Stable over expressionof Heparanase …………………………….. 47&#13;
2.2.4 Promoter reporter assay ……………………………………………48&#13;
a) Enrichment of spheres ……………………………………………. 48&#13;
b) Sdc-1 silencing in sphere cultures ………………………………… 48&#13;
c) FAK inhibitor (PF-562271) treatment ……………………………… 49&#13;
d) HPSE inhibitor (SST0001) treatment ……………………………… 49&#13;
2.2.5 Cell viability assay (MTT assay) …………………………………....49&#13;
2.2.6 Cell adhesion assay ………………………………………………...…49&#13;
2.2.7 Invasion assay ……………………………………………………..….50&#13;
2.2.8 Quantitative real-time PCR …………………………………………...50&#13;
2.2.9 Immunoblot and Immunoprecipitation ……………………………..…50&#13;
2.2.9.1 Immunoblot …………………………………………………..49&#13;
2.2.9.2 Immunoprecipitation (IP) ………………………………….…51&#13;
2.2.9.3 Zymography …………………………………………………...52&#13;
2.2.10 TOPFLASH/FOPFLASH Reporter Assay …………………………...52&#13;
2.2.11 Affymetrix microarray expression analysis ………………………….. 52&#13;
2.2.12 Flow cytometry ……………………………………………………… 53&#13;
2.2.13) Side population analysis ……………………………………. .53&#13;
2.2.14) Identification of ALDH-1 positive cells …………………….. 54&#13;
2.2.15) Cell surface marker detection ………………………………..54&#13;
2.2.16) Activated β1 integrin detection ……………………………. ...54&#13;
2.2.13 Radiation exposure ………………………………………………… ..55&#13;
2.2.14 Colonyforming assay………………………………………………. .. 55&#13;
2.2.15 NOD/SCID mouse xenograft model ………………………………... 55&#13;
2.2.16 HPSE activity assay ………………………………………………. 56&#13;
2.2.17 Statistical analysis …………………………………………………....56&#13;
3 Results: ………………………………………………………………………… 57&#13;
3.1 Part1 ………………………………………………………………………… 57&#13;
3.1.1 Silencing of Syndecan-1 enhances the cancer stem cell phenotype in&#13;
cultured human colon cancer cell lines …………………………………..57&#13;
3.1.2 Sdc-1 levels regulate self-renewal and tumorigenicity of colon CSCs …….59&#13;
3.1.3 Sdc-1 silencing has an impact on the canonical Wnt signaling pathway …..60&#13;
3.1.4 Sdc-1 knockdown induces an EMT-like phenotype in colon cancer cells….62&#13;
3.1.5 Increased FAK activation in Sdc-1depleted cells is mechanistically related to&#13;
the augmented CSC phenotype ……………………………………………..63&#13;
3.1.6 Sdc-1 siRNA knockdown modulates the stem cell phenotype, but not survival&#13;
in response to irradiation …………………………………………………..66&#13;
3.1.7 The impact of Sdc-1 depletion on the CSC phenotype is substantially&#13;
enhanced by SP enrichment ………………………………………………..69&#13;
3.1.8 Loss of Sdc-1 increases the colon cancer tumorigenicity in vivo ………….71&#13;
3.1.9 Role of Sdc-1 in colon cancer stemness - proposed model…………………72&#13;
3.1 Part2 ………………………………………………………………………… 74&#13;
3.2.1 Loss of Sdc-1 regulates the expression of HPSE …………………………...74&#13;
3.2.2 EGR1 regulates HPSE promoter activity in Sdc-1 depleted cells …………..77&#13;
3.2.3 EGR1/FAK cross-talk regulates the expression of HPSE in Sdc-1-depleted&#13;
cells ………………………………………………………………………………80&#13;
3.2.4 Role of the Syndecan-1 and heparanase axis in cancer stem cell signatures..82&#13;
3.2.5 Enhanced HPSE expression decreases Sdc-1 expression ………………… 83&#13;
3.2.6 Heparanase expression regulates the cancer stem cell phenotype ………… 86&#13;
3.2.7 Enhanced heparanase decreases the sphere formation ability in colon cancer&#13;
cell …………………………………………………………………………………87&#13;
3.2.8 Heparanase expression enhances WNT signaling and Integrin activation …89&#13;
3.2.9 Influence of heparanase expression on the radio- and chemosensitivity of&#13;
colon cancer cell…………...……………………………………………………… 91&#13;
4 Discussion: …………………………………………………………………… 93&#13;
4.1 Role of Sdc-1 in colon cancer stemness …………………………………… 93&#13;
4.2 The Sdc-1-HPSE axis in colon cancer invasion and stemness ………………98&#13;
4.3 Schematic diagram of the overall summary …………………………………108&#13;
4.4 Conclusion ………………………………………………………………… 109&#13;
5 References …………………………………………………………………… 110&#13;
6 Abbreviations …………………………………………………………………137&#13;
7 Acknowledgments …………………………………………………………… .143&#13;
8 Appendix ……………………………………………………………………….145</mods:tableOfContents>
                  <mods:targetAudience>specialized</mods:targetAudience>
                  <mods:subject>
                    <mods:topic lang="ger">Syndekan-1 ; HPSE ; Tumorstammzellen ; Signalweg ; Proteoglykan</mods:topic>
                  </mods:subject>
                  <mods:subject>
                    <mods:topic lang="eng">Proteoglycans ; Syndecan-1 ; Heparanase ; Cancer stem cells ; Wnt signaling</mods:topic>
                  </mods:subject>
                  <mods:classification authority="ddc">570</mods:classification>
                  <mods:identifier type="urn">urn:nbn:de:hbz:6-28209643005</mods:identifier>
                  <mods:location>
                    <mods:url access="object in context">https://miami.uni-muenster.de/Record/2feeeb4f-f2ef-4b1f-a725-f76997710ddb</mods:url>
                  </mods:location>
                  <mods:accessCondition type="use and reproduction">
                    <mods:extension>
                      <ma:maWrap xmlns:ma="http://memoryalpha.ulb.uni-muenster.de">
                        <ma:licence>
                          <ma:displayLabel>InC 1.0</ma:displayLabel>
                          <ma:targetUrl>https://rightsstatements.org/vocab/InC/1.0/</ma:targetUrl>
                        </ma:licence>
                      </ma:maWrap>
                    </mods:extension>
                  </mods:accessCondition>
                  <mods:recordInfo>
                    <mods:recordIdentifier>oai:wwu.de:2feeeb4f-f2ef-4b1f-a725-f76997710ddb</mods:recordIdentifier>
                  </mods:recordInfo>
                </mods:mods>
              </mets:xmlData>
            </mets:mdWrap>
          </mets:dmdSec>
          <mets:amdSec ID="AMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb">
            <mets:rightsMD ID="RIGHTSMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVRIGHTS">
                <mets:xmlData>
                  <dv:rights xmlns:dv="http://dfg-viewer.de/">
                    <dv:owner>Universitäts- und Landesbibliothek Münster</dv:owner>
                  </dv:rights>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:rightsMD>
            <mets:digiprovMD ID="DIGIPROVMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVLINKS">
                <mets:xmlData>
                  <dv:links xmlns:dv="http://dfg-viewer.de/">
                    <dv:reference>https://miami.uni-muenster.de/Record/2feeeb4f-f2ef-4b1f-a725-f76997710ddb</dv:reference>
                    <dv:presentation/>
                  </dv:links>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:digiprovMD>
          </mets:amdSec>
          <mets:fileSec>
            <mets:fileGrp USE="DEFAULT">
              <mets:file MIMETYPE="application/pdf" CHECKSUM="fde7d4f53cc1b4ee81948f8842aa77812e706578ec93a1620f9ae48b58ae503e" CREATED="2015-10-23T09:54:59" CHECKSUMTYPE="SHA-256" SIZE="10393580" ID="ID_FIL_diss_katakam.pdf_DEFAULT">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/2feeeb4f-f2ef-4b1f-a725-f76997710ddb/diss_katakam.pdf" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
            <mets:fileGrp USE="DOWNLOAD">
              <mets:file MIMETYPE="application/pdf" ID="DOW2feeeb4f-f2ef-4b1f-a725-f76997710ddb">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/transfer/miami/2feeeb4f-f2ef-4b1f-a725-f76997710ddb" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
          </mets:fileSec>
          <mets:structMap TYPE="PHYSICAL">
            <mets:div ID="ID_PHY_2feeeb4f-f2ef-4b1f-a725-f76997710ddb" TYPE="physSequence">
              <mets:div ID="ID_PHY_diss_katakam.pdf">
                <mets:fptr FILEID="ID_FIL_diss_katakam.pdf_DEFAULT"/>
              </mets:div>
            </mets:div>
          </mets:structMap>
          <mets:structMap TYPE="LOGICAL">
            <mets:div ADMID="AMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb" DMDID="DMD_2feeeb4f-f2ef-4b1f-a725-f76997710ddb" ID="ID_LOG_2feeeb4f-f2ef-4b1f-a725-f76997710ddb" TYPE="Monograph">
              <mets:div ID="ID_LOG_ID_PHY_diss_katakam.pdf"/>
            </mets:div>
          </mets:structMap>
          <mets:structLink>
            <mets:smLink xlink:from="ID_LOG_2feeeb4f-f2ef-4b1f-a725-f76997710ddb" xlink:to="ID_PHY_2feeeb4f-f2ef-4b1f-a725-f76997710ddb"/>
            <mets:smLink xlink:from="ID_LOG_ID_PHY_diss_katakam.pdf" xlink:to="ID_PHY_diss_katakam.pdf"/>
          </mets:structLink>
        </mets:mets>